• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奇异变形杆菌临床分离株产生的TEM-10β-内酰胺酶基因新变体。

New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis.

作者信息

Palzkill T, Thomson K S, Sanders C C, Moland E S, Huang W, Milligan T W

机构信息

Department of Microbiology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Antimicrob Agents Chemother. 1995 May;39(5):1199-200. doi: 10.1128/AAC.39.5.1199.

DOI:10.1128/AAC.39.5.1199
PMID:7625817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC162712/
Abstract

A clinical isolate of Proteus mirabilis was found to produce a new variant of the TEM-10 beta-lactamase gene. This is the first report of TEM-10 production by P. mirabilis and the first report of extended-spectrum beta-lactamase production by an isolate of this species recovered in the United States.

摘要

一株奇异变形杆菌临床分离株被发现可产生TEM-10β-内酰胺酶基因的一种新变体。这是奇异变形杆菌产生TEM-10的首次报道，也是在美国分离出的该菌种产超广谱β-内酰胺酶的首次报道。

相似文献

1
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis.奇异变形杆菌临床分离株产生的TEM-10β-内酰胺酶基因新变体。
Antimicrob Agents Chemother. 1995 May;39(5):1199-200. doi: 10.1128/AAC.39.5.1199.
2
Emerging extended-spectrum beta-lactamases in Proteus mirabilis.奇异变形杆菌中新型超广谱β-内酰胺酶的出现
J Clin Microbiol. 2002 Apr;40(4):1549-52. doi: 10.1128/JCM.40.4.1549-1552.2002.
3
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.奇异变形杆菌临床分离株产生的TEM-89β-内酰胺酶：一种新型复合突变体（CMT 3），在TEM-59（IRT-17）和TEM-3中均有突变。
Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4. doi: 10.1128/AAC.45.12.3591-3594.2001.
4
TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.TEM-187，一种新的超广谱β-内酰胺酶，在奇异变形杆菌临床株中活性较弱。
Antimicrob Agents Chemother. 2013 May;57(5):2410-2. doi: 10.1128/AAC.01761-12. Epub 2013 Mar 11.
5
Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.台湾地区产CTX-M型超广谱β-内酰胺酶奇异变形杆菌分离株的分子流行病学研究
Int J Antimicrob Agents. 2015 Jan;45(1):84-5. doi: 10.1016/j.ijantimicag.2014.09.004. Epub 2014 Sep 29.
6
The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.在多种产β-内酰胺酶的奇异变形杆菌临床分离株中首次检测到CTX-M-14超广谱β-内酰胺酶
Diagn Microbiol Infect Dis. 2006 Mar;54(3):237-9. doi: 10.1016/j.diagmicrobio.2005.09.013. Epub 2006 Jan 19.
7
Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.在一项意大利调查中，奇异变形杆菌分离出的一种新型超广谱β-内酰胺酶（TEM-87）的特性分析。
Antimicrob Agents Chemother. 2002 Mar;46(3):925-8. doi: 10.1128/AAC.46.3.925-928.2002.
8
New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.奇异变形杆菌和斯氏普罗威登斯菌分离株产生的新型 TEM 变体（TEM-92）。
Antimicrob Agents Chemother. 2001 Apr;45(4):1278-80. doi: 10.1128/AAC.45.4.1278-1280.2001.
9
Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.奇异变形杆菌韩国分离株中广谱β-内酰胺酶和质粒介导的AmpCβ-内酰胺酶的出现情况
J Antimicrob Chemother. 2006 Jan;57(1):156-8. doi: 10.1093/jac/dki408. Epub 2005 Nov 10.
10
Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.日本迅速传播的产 CTX-M 型超广谱β-内酰胺酶奇异变形杆菌。
Int J Antimicrob Agents. 2010 Oct;36(4):340-2. doi: 10.1016/j.ijantimicag.2010.06.002. Epub 2010 Jul 7.

引用本文的文献

1
First Report of Complete Genome Analysis of Multiple Drug Resistance KUST-1312 Isolate From Migratory Birds in China: A Public Health Threat.中国候鸟中多重耐药性KUST - 1312分离株全基因组分析的首次报告：对公共卫生的威胁
Transbound Emerg Dis. 2024 Oct 3;2024:8102506. doi: 10.1155/2024/8102506. eCollection 2024.
2
Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.尼泊尔一家三级护理中心获得的社区获得性多重耐药临床分离大肠杆菌。
Antimicrob Resist Infect Control. 2015 May 1;4:15. doi: 10.1186/s13756-015-0059-2. eCollection 2015.
3
TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.TEM-187，一种新的超广谱β-内酰胺酶，在奇异变形杆菌临床株中活性较弱。
Antimicrob Agents Chemother. 2013 May;57(5):2410-2. doi: 10.1128/AAC.01761-12. Epub 2013 Mar 11.
4
Expanded molecular diversity generation during directed evolution by trinucleotide exchange (TriNEx).通过三核苷酸交换（TriNEx）在定向进化过程中扩展分子多样性的产生。
Nucleic Acids Res. 2008 Aug;36(13):e77. doi: 10.1093/nar/gkn358. Epub 2008 Jun 17.
5
Emerging extended-spectrum beta-lactamases in Proteus mirabilis.奇异变形杆菌中新型超广谱β-内酰胺酶的出现
J Clin Microbiol. 2002 Apr;40(4):1549-52. doi: 10.1128/JCM.40.4.1549-1552.2002.
6
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.21世纪的超广谱β-内酰胺酶：这种重要耐药威胁的特征、流行病学及检测
Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents. doi: 10.1128/CMR.14.4.933-951.2001.
7
Controversies about extended-spectrum and AmpC beta-lactamases.关于超广谱β-内酰胺酶和AmpCβ-内酰胺酶的争议。
Emerg Infect Dis. 2001 Mar-Apr;7(2):333-6. doi: 10.3201/eid0702.010238.
8
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital.1072株奇异变形杆菌临床菌株中β-内酰胺酶的流行情况：法国一家医院的为期两年的调查。
Antimicrob Agents Chemother. 2000 Jul;44(7):1930-5. doi: 10.1128/AAC.44.7.1930-1935.2000.
9
Diversity of TEM mutants in Proteus mirabilis.奇异变形杆菌中透射电子显微镜（TEM）突变体的多样性。
Antimicrob Agents Chemother. 1999 Nov;43(11):2671-7. doi: 10.1128/AAC.43.11.2671.
10
Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 beta-lactamase.一株产TEM-10β-内酰胺酶的耐头孢他啶摩根氏摩根菌分离株的分子特征分析
Antimicrob Agents Chemother. 1999 Feb;43(2):434-5. doi: 10.1128/AAC.43.2.434.

本文引用的文献

1
Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.欧洲败血症分离株中大肠杆菌和克雷伯菌属的超广谱β-内酰胺酶
J Antimicrob Chemother. 1993 Oct;32(4):559-70. doi: 10.1093/jac/32.4.559.
2
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.来自单一中心的具有遗传多样性的耐头孢他啶分离株：不同核苷酸序列编码的TEM-10β-内酰胺酶的生化和遗传学特征
Antimicrob Agents Chemother. 1993 Sep;37(9):1989-92. doi: 10.1128/AAC.37.9.1989.
3
Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes.MGH-1、YOU-1和YOU-2超广谱β-内酰胺酶基因序列。
Antimicrob Agents Chemother. 1993 Dec;37(12):2760-1. doi: 10.1128/AAC.37.12.2760.
4
Extended-spectrum beta-lactamase in Proteus mirabilis.奇异变形杆菌中的超广谱β-内酰胺酶
J Antimicrob Chemother. 1994 May;33(5):925-35. doi: 10.1093/jac/33.5.925.
5
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.产超广谱β-内酰胺酶导致肠杆菌科细菌对新型β-内酰胺类药物产生可转移耐药性：医院流行情况及药敏模式
Rev Infect Dis. 1988 Jul-Aug;10(4):867-78. doi: 10.1093/clinids/10.4.867.
6
Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.新型质粒介导的β-内酰胺酶（TEM-10）赋予肺炎克雷伯菌临床分离株对头孢他啶和氨曲南的选择性耐药性。
Antimicrob Agents Chemother. 1989 Sep;33(9):1451-6. doi: 10.1128/AAC.33.9.1451.
7
Extended-spectrum beta-lactamases.超广谱β-内酰胺酶
Antimicrob Agents Chemother. 1989 Aug;33(8):1131-6. doi: 10.1128/AAC.33.8.1131.
8
A standard numbering scheme for the class A beta-lactamases.A类β-内酰胺酶的标准编号方案。
Biochem J. 1991 May 15;276 ( Pt 1)(Pt 1):269-70. doi: 10.1042/bj2760269.
9
More extended-spectrum beta-lactamases.更多超广谱β-内酰胺酶
Antimicrob Agents Chemother. 1991 Sep;35(9):1697-704. doi: 10.1128/AAC.35.9.1697.
10
In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis.奇异变形杆菌临床分离株中一种新的质粒介导的氧亚氨基头孢菌素酶导致的体外和体内可转移的β-内酰胺耐药性
Microbiol Immunol. 1991;35(2):87-97. doi: 10.1111/j.1348-0421.1991.tb01537.x.